GLP-1s, explained before you start

What GLP-1 actually means

GLP-1 stands for glucagon-like peptide-1, a hormone your gut produces naturally after you eat. It does several things: tells your pancreas to release insulin when blood sugar rises, slows how quickly your stomach empties, and signals your brain that you're satisfied.

GLP-1 receptor agonists are synthetic versions of this hormone, engineered to last longer in your system than the native peptide. The medications you've heard about—semaglutide, tirzepatide, liraglutide—are all GLP-1 receptor agonists, though some also target additional hormone pathways.

How they work for weight loss

These medications weren't designed for weight loss first. They were developed to manage type 2 diabetes by improving blood sugar control. Weight loss emerged as a consistent side effect, significant enough that higher-dose formulations were later approved specifically for obesity.

The weight loss happens through several mechanisms. Slower gastric emptying means food stays in your stomach longer, extending the feeling of fullness. Central appetite suppression reduces food-seeking behavior and portions. Some users report that "food noise"—constant thoughts about eating—goes quiet.

The effect is substantial for many people, but highly individual. Clinical trials show average weight loss, not guaranteed outcomes for every person.

Why they're prescription-only

GLP-1 receptor agonists require a prescription because they carry real risks and contraindications that need medical evaluation.

They can cause nausea, vomiting, diarrhea, and constipation, especially during dose escalation. More serious risks include pancreatitis, gallbladder problems, and potential thyroid effects. They're contraindicated in people with certain medical histories, including medullary thyroid carcinoma and multiple endocrine neoplasia syndrome type 2.

Dosing must be individualized and titrated carefully. Starting too high or increasing too quickly amplifies side effects. Managing the medication during illness, surgery, or other life events requires clinical judgment.

Pregnancy is an absolute contraindication—these medications must be stopped months before conception. Drug interactions exist. Kidney function matters for some formulations.

This isn't gatekeeping. It's recognition that these are potent medications affecting multiple organ systems.

Who they're indicated for

In the United States, GLP-1 receptor agonists for weight management are FDA-approved for adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related condition like hypertension, type 2 diabetes, or dyslipidemia.

They're not cosmetic medications for people at healthy weights who want to lose a few pounds. The risk-benefit calculation changes substantially when there's no metabolic indication.

Your prescriber will evaluate your full medical history, current medications, and whether you've tried lifestyle interventions first. They'll monitor you during treatment.

What they don't do

GLP-1 medications are not metabolic resets that permanently change your weight set point. When you stop, the hormonal effects stop. Weight regain is common without ongoing intervention, whether that's continued medication or sustained behavior change.

They don't address the environmental, psychological, or socioeconomic factors that contribute to weight. They don't build muscle or improve insulin sensitivity through the mechanisms that exercise does. They don't teach you anything about nutrition.

They're tools, not solutions. Effective tools for many people, but tools nonetheless.

The compounding question

Shortages of brand-name GLP-1 medications led to an increase in compounded versions from specialized pharmacies. Compounded medications are not FDA-approved. They may be appropriate in specific circumstances, but they carry different quality assurance standards and legal protections.

If you're considering a compounded GLP-1, have a direct conversation with a prescriber about why that's the recommendation, what the source is, and how you'll be monitored. Compounding is a legitimate practice, but it's not equivalent to FDA-approved products.

Before you start

If you're interested in GLP-1 therapy, start with a licensed healthcare provider who can assess your individual situation. Be honest about your goals, your history, and what you're hoping the medication will do.

Ask about monitoring, side effect management, duration of treatment, and what happens when you stop. Ask what else needs to happen alongside the medication—movement, nutrition, sleep, stress.

These are powerful medications with real benefits for the right people in the right context. That context includes medical supervision.